04/07/2024 11:15 PM | Aura Biosciences (Filer)
| Form EFFECT | |
04/04/2024 3:10 PM | Aura Biosciences (Issuer) Kilroy Conor (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/27/2024 6:59 AM | Aura Biosciences (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/27/2024 7:12 AM | Aura Biosciences (Filer)
| Form S-3 Registration statement under Securities Act of 1933 | |
03/27/2024 6:11 AM | Aura Biosciences (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
03/27/2024 6:05 AM | Aura Biosciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/23/2024 3:22 PM | Aura Biosciences (Subject) Rich Cadmus (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
|
02/14/2024 3:57 PM | Aura Biosciences (Subject) CITADEL ADVISORS LLC (Filed by)
| Form SC 13G/A | |
02/07/2024 6:54 AM | ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by) Aura Biosciences (Subject)
| Form SC 13G/A | |
01/24/2024 3:20 PM | Aura Biosciences (Issuer) de los Pinos Elisabet (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/08/2024 6:31 AM | Aura Biosciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/02/2024 3:29 PM | Aura Biosciences (Subject) Rich Cadmus (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/15/2023 3:30 PM | Aura Biosciences (Subject) Rich Cadmus (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/09/2023 3:20 PM | Aura Biosciences (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
11/07/2023 5:09 PM | Aura Biosciences (Issuer) Feder Julie B (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/07/2023 5:19 PM | Aura Biosciences (Issuer) de los Pinos Elisabet (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/07/2023 3:55 PM | Aura Biosciences (Filer)
| Form 424B5 | |
11/06/2023 3:17 PM | Aura Biosciences (Filer)
| Form 424B5 | |
11/06/2023 3:20 PM | Aura Biosciences (Subject) Feder Julie B (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/06/2023 3:22 PM | Aura Biosciences (Subject) de los Pinos Elisabet (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/01/2023 5:21 PM | Aura Biosciences (Issuer) de los Pinos Elisabet (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/01/2023 5:24 PM | Aura Biosciences (Issuer) Feder Julie B (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/23/2023 7:51 PM | Aura Biosciences (Issuer) Hopkins Janet Jill (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
10/05/2023 6:56 PM | Aura Biosciences (Issuer) Johnson David Michael (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/02/2023 3:11 PM | Aura Biosciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/09/2023 6:05 AM | Aura Biosciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/09/2023 6:10 AM | Aura Biosciences (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
06/07/2023 4:46 PM | Aura Biosciences (Subject) De Rosch Mark (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/07/2023 3:52 PM | Aura Biosciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/02/2023 6:11 PM | Aura Biosciences (Subject) De Rosch Mark (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |